Profile
Robert L Coleman is currently a Professor at the University of Texas Health Center, Chief Scientific Officer & Senior Vice President at US Oncology Research LLC, and Chief Marketing Officer at Sarah Cannon Research Institute LLC.
Formerly, Dr. Coleman was Co-Director at The Gynecologic Oncology Group and Independent Director at Valerio Therapeutics SA.
Robert Coleman active positions
| Companies | Position | Start |
|---|---|---|
University of Texas Health Center
University of Texas Health Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
US Oncology Research LLC
US Oncology Research LLC Medical/Nursing ServicesHealth Services Provides cancer healthcare services | Chief Tech/Sci/R&D Officer | - |
Sarah Cannon Research Institute LLC
Sarah Cannon Research Institute LLC Miscellaneous Commercial ServicesCommercial Services Offers management, regulatory and other research support services for drug development | Sales & Marketing | - |
Former positions of Robert Coleman
| Companies | Position | End |
|---|---|---|
The Gynecologic Oncology Group | Director/Board Member | - |
| VALERIO THERAPEUTICS | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
US Oncology Research LLC
US Oncology Research LLC Medical/Nursing ServicesHealth Services Provides cancer healthcare services | Health Services |
Valerio Therapeutics SA
Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Texas Health Center
University of Texas Health Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sarah Cannon Research Institute LLC
Sarah Cannon Research Institute LLC Miscellaneous Commercial ServicesCommercial Services Offers management, regulatory and other research support services for drug development | Commercial Services |
The Gynecologic Oncology Group |
- Stock Market
- Insiders
- Robert Coleman
















